[Federal Register Volume 75, Number 107 (Friday, June 4, 2010)]
[Notices]
[Pages 31795-31796]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13484]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities; Recombinant DNA Research:
Amended Notice of Meeting
ACTION: Notice of cancellation of consideration of a proposed action
[[Page 31796]]
under Section III-A-1 of the NIH Guidelines for Research Involving
Recombinant DNA Molecules (NIH Guidelines).
-----------------------------------------------------------------------
SUMMARY: Notice of a discussion of a proposed action under Section III-
A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The
discussion that was to be held at the June 16-17, 2010 meeting of the
NIH Recombinant DNA Advisory Committee has been deferred at the request
of the principal investigator.
FOR FURTHER INFORMATION CONTACT: OBA by e-mail at [email protected], or
telephone at 301-496-9838, if you have questions, or require additional
information.
Dated: May 26, 2010.
Jacqueline Corrigan-Curay,
Acting Director, Office of Biotechnology Activities, National
Institutes of Health.
[FR Doc. 2010-13484 Filed 6-3-10; 8:45 am]
BILLING CODE 4140-01-P